Shift Toward Comprehensive Marker Evaluation, Universal Screening for Breast Cancer Risk Assessment

Paralleling trends in other clinical areas, breast cancer risk testing is transitioning from single-marker testing to more comprehensive analysis. This broadened focus extends to both wider analysis … [Read more...]

Trend Toward Panels, NGS for Breast Cancer-Associated Testing Seen at San Antonio Breast Cancer Symposium

Trend Toward Panels, NGS for Breast Cancer-Associated Testing Seen at San Antonio Breast Cancer Symposium Researchers are forging ahead on utilization of markers across the spectrum of breast cancer … [Read more...]

With Flu Epidemic, Better Diagnostics Become Focus

While Ebola was the infectious disease grabbing most of the headlines in the last year, experts say it is actually the flu that should have us most worried domestically. In the closing days of 2014, … [Read more...]

‘Solid’ Year Expected for Diagnostics Industry in 2015; Concentrated VC Investments Expected

2014 was a record-setting year by many business metrics for the biotechnology industry. The volume of initial public offerings by venture-backed life science companies was high, mergers and … [Read more...]


(-00000g2)